Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis

European Journal of Cancer

Volumn 42, Issue 14, 2006, Pages 2382-2389

  Pace, Elisabetta ^a   Siena, Liboria ^a   Ferraro, Maria ^a   Profita, Mirella ^a   Mondello, Patrizia ^b   Chiappara, Giuseppina ^a   Marina Montalbano, Angela ^a   Giarratano, Antonino ^c   Bonsignore, Giovanni ^a   Gjomarkaj, Mark ^a  

^a CNR   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cancer; PGE2; Pleura

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RECEPTOR SUBTYPE; TALC;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CELL PROTECTION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXUDATE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; PLEURISY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NF-KAPPA B; PLEURAL EFFUSION, MALIGNANT; PLEURISY; RECEPTORS, PROSTAGLANDIN E; TALC; UP-REGULATION;

EID: 33748118271     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.03.022     Document Type: Article

References (31)

1. Antony V.B., Loddenkemper R., Astoul P., et al. Management of malignant pleural effusions. Eur Respir J 18 (2001) 402-419
2. Kroegel C., and Antony V.B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 10 (1997) 2411-2418
3. Karin M., and Greten F.R. NF-κB: linking inflammation and immunity to cancer development and progression. Nature Rev Immunol 5 (2005) 749-759
4. Dohadwala M., Batra R.K., Luo J., et al. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 277 (2002) 50828-50833
5. Dannenberg A.J., Altorki N.K., Boyle J.O., et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2 (2001) 544-551
6. Riedl K., Krysan K., Pold M., et al. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat 7 (2004) 169-184
7. Zweifel B.S., Davis T.W., Ornberg R.L., and Masferrer J.L. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res 62 (2002) 6706-6711
8. Spatafora M., Chiappara G., D'Amico D., Volpes D., Pace E., and Merendino A.M. Prostaglandin E2 down-regulates the expression of tumor necrosis alpha gene by human blood monocytes. Adv Prostaglandin Thromboxane Leukot Res 21B (1991) 521-524
9. Light R.W. Pleural diseases. Dis Mon 38 (1992) 261-331
10. Nasreen N., Mohammed K.A., Dowling P.A., Ward M.J., Galffy G., and Antony V.B. Talc induces apoptosis in human malignant mesothelioma cells in vitro. Am J Respir Crit Care Med 161 (2000) 595-600
11. Dohadwala M., Luo J., Zhu L., et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 276 (2001) 20809-20812
12. Profita M., Sala A., Bonanno A., et al. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 112 (2003) 709-716
13. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
14. Haslett J.N., Sanoudou D., Kho A.T., et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 99 (2002) 15000-15005
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T) methods. 2001;25:402-8.
16. Pace E., Gagliardo R., Melis M., et al. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. J Allergy Clin Immunol 114 (2004) 1216-1223
17. Pace E., Melis M., Siena L., et al. Effects of gemcitabine on cell proliferation and apoptosis in non-small-cell lung cancer (NSCLC) cell lines. Cancer Chemother Pharmacol 46 (2000) 467-476
18. Shishodia S., Koul D., and Aggarwal B.B. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 173 3 (2004) 2011-2022
19. Shishodia S., and Aggarwal B.B. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res 64 14 (2004) 5004-5012
20. Gentile A., and Comoglio P.M. Invasive growth: a genetic program. Int J Dev Biol 48 (2004) 451-456 Review
21. Marx J. Inflammation and cancer: the link grows stronger. Science 306 (2004) 966-968
22. Khuri F.R., Wu H., Lee J.J., et al. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res 7 (2001) 861-867
23. Cianchi F., Cortesini C., Fantappiè O., et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10 (2004) 2694-2704
24. Brown J.R., and DuBois R.N. Cyclooxygenase as a target in lung cancer. Clin Cancer Res 10 (2004) 4266S-4269S
25. Yoon J.M., Lim J.J., Yoo C.G., et al. Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-kappaB activity in lung cancer cells. Lung Cancer 48 2 (2005) 201-209
26. Krysan K., Reckamp K.L., Dalwadi H., et al. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65 14 (2005) 6275-6281
27. Tsujii M., and DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 83 (1995) 493-501
28. 1 delay in intestinal epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 56 (1996) 733-737
29. Melis M., Pace E., Siena L., et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med 167 8 (2003) 1131-1138
30. Altorki N.K., Port J.L., Zhang F., et al. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer. Clin Cancer Res 11 (2005) 4191-4197
31. Huang M., Stolina M., Sharma S., et al. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: upregulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 58 6 (1998) 1208-1216